Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Hematologic Malignancy Milestones

George Canellos

MD

🏢Dana-Farber Cancer Institute / Harvard Medical School🌐USA

William Rosenberg Professor of Medicine, Emeritus

92
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

George Canellos is a pioneer of combination chemotherapy who demonstrated that ABVD was superior to MOPP for Hodgkin lymphoma, establishing the regimen that remains standard of care today. His clinical trials at Dana-Farber defined modern lymphoma treatment approaches. He has trained generations of hematologic oncologists who continue to advance the field.

Share:

🧪Research Fields 研究领域

ABVD chemotherapy
Hodgkin lymphoma treatment
Combination chemotherapy
Lymphoma clinical trials
Medical oncology history

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 George Canellos 的研究动态

Follow George Canellos's research updates

留下邮箱,当我们发布与 George Canellos(Dana-Farber Cancer Institute / Harvard Medical School)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment